{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"CTNNB1 (\u03b2-catenin), a transcriptional activator, is recurrently mutated in various cancers including endometrial and hepatocellular cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"11/16/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "26619011",
        "9537226",
        "18358501",
        "18540944"
      ]
    },
    "description":"The CTNNB1 S37C mutation is located in the N-terminus of the protein. This mutation has been found in liver cancer and craniopharyngioma and is a statistically significant hotspot (PMID: 18358501, 18540944, 26619011). While this mutation has not yet been functionally characterized, endogenous expression of this mutation in an endometrial cancer sample demonstrated increased protein expression compared to samples expressing wildtype (PMID: 9537226).",
    "knownEffect":"Likely Gain-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"S37C",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":1499,
    "hgvs":null,
    "hugoSymbol":"CTNNB1",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The CTNNB1 S37C mutation is likely oncogenic.",
  "vus":false
}